ABSTRA CT Serum samples were obtained from 21 normal human fetuses after therapeutic abortion for psychiatric indications. Fetal crown-rump length ranged from 5.2 to 22.5 cm, corresponding to the gestational age of 65-168 days.
INTRODUCTION
The functional and anatomical development of the fetal thyroid and pituitary glands has been partially characterized in earlier studies. Shepard has described the morphologic differentiation of the human fetal thyroid (1) and the onset of iodothyronine and iodotyrosine production (2) . Studies of fetal pituitary embryogenesis by Pearse (3) and Rosen and Ezrin (4) delineated the cytologic differentiation of the pituitary basophil and thyrotroph cells; and recently Gitlin and Biasucci (5) described the ontogenesis of thyroid-stimulating hormone production in fetal pituitary tissue cultures.
The present study was undertaken to correlate the appearance of thyroid-stimulating hormone (TSH) and thyroxine in the circulation of the human fetus and to examine the relation of each to the other and to the thyroxine-binding proteins during fetal development. In addition, we have investigated these parameters in paired maternal and fetal sera in an attempt to define the relation of material and fetal thyroid function.
METHODS
Subjects. 21 grossly normal human fetuses were obtained immediately after therapeutic abortion. Blood was drawn by cardiac puncture and/or cord exsanguination. Seven maternal sera were obtained before anesthesia was admin-istered for the hysterotomy. All pregnancies were uncomplicated, and all abortions were done for psychiatric indications only. Paired maternal and cord sera from normal full-term newborns were also examined.
Methods. Serum thyroxine was determined by the modified method of Murphy and Jachan (6) using the Tetrasorb Kit (Abbott Laboratories Ltd., Queenborough, Kent, Eng.).
Results are expressed as Atg/100 ml of thyroxine corrected for the recovery of the extraction.
Thyroxine-binding globulin binding capacity (TBG) was assessed using reverse-flow paper electrophoresis in glycine acetate buffer, pH 8.6 (7) . Each serum was enriched with 5.7 gg/100 ml of thyroxine-"I11 (T4-'31I). Sera from older fetuses were assayed with 50 and 100 ,g/100 ml of added L-thyroxine to determine maximal binding capacity, and sera from younger fetuses with 25 and 50 gtg/l00 ml.
Maximal binding capacity of maternal sera was assessed with 300 and 400 ug/100 ml of added L-thyroxine, and fullterm infants with 200 and 300 ,ug/100 ml. Thyroxine-binding prealbumin binding capacity (TBPA) was assessed with 800 and 1000 Atg/100 ml of added L-thyroxine in all specimens. The relative distribution of T4-1311 between the fetal thyroxine-binding proteins was determined after the addition of 1.5 ,ug/100 ml of T4-'31I. A current of 12.0 ma was applied for 18 hr and the electrophoresis strips were dried and then scanned for radioactivity in an automatic gas flow 0 24.7 14.9WK FIGURE 1 B Thyroxine-"31I distribution in four fetal sera of decreasing gestational age. All sera contain 50 ug/100 ml of L-thyroxine and 5.7 ,g/100 ml of thyroxine-"31I. The upper row represents the tracings of the automatic gas flow counterscan, and the middle row represents the radioautographs of the electrophoretic strips. In the lower row the same strips are stained with bromphenol blue to illustrate the position of the albumin. The anode is to the right. The 14.9 wk fetus, on the right, has little thyroxine-"lI bound to the TBG, while most is bound to TBPA. TBG-bound thyroxine-"'I then increases with advancing fetal maturity.
counter. The distribution of radioactivity was assessed by manual planimetry. (8) . Purity of the T4-j"I (Abbott Laboratories Ltd.) was determined by thin-layer chromatography on cellulose plates using a two-dimensional system (9) . Thyroxine accounted for 94.4% of the radioactivity, iodide for 3.9%, and triiodothyronine for 1.7%o. The T4-"I was then dialyzed against 8 Fig. 1 . The crown-rump length is plotted with the corresponding gestational age as predicted by Streeter (12) . The serum of the second smallest fetus (78 days gestation) contained thyroxine. None was detectable in a fetus of 74 days gestation; however, sufficient serum was not available for extraction of more than a 500 AI sample. The serum thyroxine levels increased linearly from 78 days to 24 wk gestation. These values correlated significantly with the crown-rump length (r= 0.857, P < 0.001). Thyroxine-binding globulin (1.4 /g/ 100 ml) was present in the serum of the youngest fetus assayed (78 days). Fetal TBG increased linearly when related to crown-rump length (r = 0.864, P < 0.001) (Figs. lA and iB). Expressing serum thyroxine and TBG concentration as a percentage of the 24-cm fetal levels predicted by the respective regression lines, the relative rates of change of the two parameters can be estimated (Fig. 2) . By the analysis of linear covariance, the rates of increase in TBG and thyroxine levels were not significantly different (F = 1.58, P > 0.5). The interpretation of the statistical analysis, however, is limited by the large variation about the regression lines due primarily to the small sample size in both groups. It can be noted in Fig. 2 that the thyroxine levels do appear to be increasing at a slightly more rapid rate than TBG levels.
The maximal binding capacity of TBPA in eight fetal sera ranging from 11.5 to 23.8 wk estimated gestational age and in nine full-term newborns is given in Table I . All fetal specimens were within the newborn range. However, both fetal and newborn TBPA are significantly lower than that seen in children 5-12 yr of age (299 ±38 (SEM) Ag/100 ml. The distribution of tracer amounts of T4-"3.I between the thyroxine-binding proteins of fetal sera is illustrated in Fig. 3 A fetal protein, originally described by Bergstrand and Czar (13) as fetal X substance, with electrophoretic migration characteristically occurring between albumin and a,-globulin, was identified by microelectrophoresis on a cellulose acetate membrane (Fig. 4 Free thyroxine concentration (FT4) in 13 fetal sera correlated directly with the crown-rump length (r= 0.908, P <0.001). By [18] [19] [20] wk gestation the FT4 was comparable with that observed in fetuses of 38 wk gestation (Fig. 5A ). This contrasted with the total serum thyroxine concentration, which maintained a linear relation to gestational age but continued to increase until term (Fig. 1A) . The free thyroxine fraction (FT4F) decreased linearly as related to crown-rump length (Fig. 5B) .
Radioimmunoassayable TSH was detected in the smallest fetus examined at 78 days gestation (Fig. 6 ). This sample, however, had a high TSH level compared with most of the fetuses in the 11-14 wk period of gestation. The remainder of the young fetuses have TSH levels of 4 #U/cc or less until 16-18 wk. Specimens older than 18 wk were within the range of term sera.
All but one of the fetal sera examined bad values 1796 Greenberg, Czernichow, Reba, Tyson, and Blizzard correlation was demonstrated between TSH and FT4 through the range of fetal specimens examined (Fig. 7) . FT4 concentrations were determined in five paired maternal and fetal sera and 16 paired maternal and term infant sera (Fig. 8) . No difference was demonstrated between the maternal and term sera (t = 1.11, P > 0.2). However, significantly higher maternal levels were noted earlier in fetal life, and this difference decreased with advancing gestation.
The TSH levels determined on similary paired sera indicated a significant difference between maternal and term sera by a paired t test (t = 5.90, P < 0.01; Fig. 9 ). Correspondingly higher fetal TSH levels were found for most of the gestational period except for the two fetuses in the 11-13 wk range. The high TSH value noted in the youngest fetus of the series was associated with an elevated maternal value. This is the only maternal TSH that was observed to exceed that of the paired fetus or newborn. DISCUSSION The histological and functional differentiation of the thyroid and pituitary glands in the human fetus is summarized in Fig. 10 (14) , and Gitlin and Biasucci (5) have recently reported that fetal pituitaries are capable of incorporating amino acids-14C into TSH in cell culture at 14 wk gestation.
The fetal thyroid gland is capable of organically binding iodine and forming iodothyronines by 10 wk gestation (2) . This corresponds to the period of differentiation in which intracellular canaliculi have undergone extracellular fusion, and colloid formation is first noted (1, 2) . It is, however, at least 6 wk after thyroglobulin synthesis is detected (15) .
In the present study thyroxine was identified in serum at 78 days but not at 74 days gestation, indicating that it appears about 1 wk after the initiation of intrathyroidal synthesis. It is possible, however, that with more concentrated serum extracts in the younger fetuses, thyroxine could be identified earlier. Protein-bound iodine has been detected in fetal sera as early as 13 wk gestation ( 16) . Thyroxine-binding globulin and thyroxine-binding prealbumin have been identified as early as 74 days estimated gestational age (16) . Specimens from younger fetuses have not been examined for these thyroxinebinding proteins. Albumin in significant quantity was detected in a fetus of 64 days estimated gestational age in the present study. The fetal postalbumin, a-fetoprotein, was detected in largest quantity in the youngest fetus studied. Its role as a thyroxine-binding protein, however, has not been well studied.
It was observed that TBG binding, measured as the percentage of tracer amounts of T4-1"I associated with TBG, is much greater than that seen in adults or children. At 20 wk gestation, with TBG capacity of 7.7 /Ag/100 ml, fetal TBG is able to bind 78% of tracer T4-'I. Adult sera with much higher TBG capacity (males 15.6 +2.9 (SD) /g/100 ml; females 18.0 ±2.9 (SD) ug/100 ml) bind slightly less tracer (males 70.9 +-4.7 (SD) %; females 76.9 +4.1 (SD) %).
In an attempt to distinguish the effects of relatively low concentrations of albumin and TBPA on the distribution of tracer, and the possibility that fetal TBG Using the Robbins and Rall formulation (17) secretion in the fetus is responsive to FT4 levels from very early in gestation, possibly as early as 11 wk. It seems unlikely that the parallel changes represent independent maturation and autonomous secretion of hormones of the thyroid and pituitary glands. In addition, the rise in FT4 levels, which occurs in the face of a simultaneous increase in TBG, would indicate that TSH stimulation of thyroxine secretion is responding as if it were being stimulated by suboptimal levels of circulating thyroxine. The attempt to demonstrate that thyroxine secretion and the rise in serum thyroxine levels were occurring at a more rapid rate than increases in TBG concentration was not possible (Fig. 2) . However, the observed increase in FT4 levels allows an assumption of this relationship.
Fetal TSH levels after 16 wk gestation are high compared with normal children or adults. Why TSH is maintained at high levels during most of fetal life is difficult to explain. It is unlikely that this represents cross-reactivity with human chorionic gonadotropin (HCG) or human chorionic thyrotropin (HCT). Excess HCG is added to the antiserum to saturate reactive binding sites (18) , and HCT has been demonstrated to react very poorly with the NIAMD HTSH antiserum (19, 20) . It No correlation was demonstrated between maternal TSH levels and any of the parameters of fetal thyroid function. This probably reflects the inability of maternal TSH to cross the placenta. A more important question, however, is whether free thyroxine crosses the placenta in quantities sufficient to affect the developing fetus. At term both L-thyroxine (22, 23) and triiodothyronine (24, 25) are capable of crossing the human placenta, but with some difficulty. It has been estimated in primates that only 0.01% of the total thyroxine utilized by the fetus late in pregnancy is of maternal origin (26) .
In the present study a large maternal to fetal gradient of free thyroxine was found during early fetal life, and this decreased with advancing gestation. This would suggest that some contribution of maternal thyroxine is possible in the young fetus. Even if occurring, this contribution would certainly decrease later in fetal development, as fetal free-thyroxine concentration approaches term levels. It is also manifest that in the absence of evidence for a thyroxine pump, a significant block to the transplacental movement of thyroid hormone must be postulated even in early fetal life. One question that remains unanswered is whether the small amounts of thyroxine which are able to cross the placenta during early gestation are necessary for fetal maturation. Animal evidence would suggest that neither fetal nor maternal thyroxine is necessary for most fetal growth. Hamburgh, Lynn, and Weiss (27) showed that propylthiouracil-fed fetal rats have normal skeletal and cerebral maturation at birth and retain normal puzzlesolving skills if thyroxine replacement was begun immediately after delivery. This is not the experience in humans, as early thyroxine replacement in cretins is still associated with a significant degree of retardation in some (28) . This finding, however, may be the result of a deficiency of thyroid hormone during the late stages of fetal development when fetal thyroid function is at optimal levels. The role of maternal thyroxine, if any, remains unknown in very early fetal development. Greenberg, Czernichow, Reba, Tyson, and Blizzard 
